09.12.16 +0,72%
Aktien New York Schluss: Ungebrochene Kauflust sorgt für weitere Rekorde

AREVA: Conditions of Availability or Consultation of the Information Relating to the Extraordinary Shareholders’ Meeting of November 3, 2016

Dienstag, 18.10.2016 20:40


Regulatory News:

The extraordinary Shareholders’ meeting of AREVA (Paris:AREVA) will be held on Thursday, November 3, 2016 at 11 a.m., at the AREVA Tower, 1 Place Jean Millier – 92400 Courbevoie (France).

The preliminary notice comprising the agenda and the draft resolutions was published in the Bulletin des Annonces Légales Obligatoires n° 117 on September 28, 2016. The text of the draft resolutions, which shall be submitted to the Shareholders’ Meeting, are listed in the notice of meeting published in the Bulletin des Annonces Légales Obligatoires n° 125 on October 17, 2016. Conditions for participating and voting at the Shareholders’ Meeting are described in these notices.

Documents and information regarding the Shareholders’ Meeting are available to shareholders under the conditions provided for by law and/or published on the internet web site of the company (Shareholders’ Meeting section).


AREVA supplies high added-value products and services to support the operation of the global nuclear fleet.

The company is present throughout the entire nuclear cycle, from uranium mining to used fuel recycling, including nuclear reactor design and operating services.

AREVA is recognized by utilities around the world for its expertise, its skills in cutting-edge technologies and its dedication to the highest level of safety. AREVA’s 40,000 employees are helping build tomorrow’s energy model: supplying ever safer, cleaner and more economical energy to the greatest number of people.

View source version on

(c)Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.